Quick Takeaways
- ACORN BIOVENTURES, L.P. filed SCHEDULE 13G/A for Mural Oncology plc Common Stock, $0.01 par value per share (MURA).
- Disclosed ownership: 7.6%.
- Date of event: 31 Dec 2024.
ACORN BIOVENTURES, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Mural Oncology plc Common Stock, $0.01 par value per share (MURA)
- Filing Manager
- ACORN BIOVENTURES, L.P.
- Reporting Manager
- Anders Hove
- Symbol
- MURA
- Shares outstanding
- 16,922,092 shares
- Disclosed Ownership
- 1,286,079 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:18:40 UTC
- Date of event
- 31 Dec 2024
- Previous filing
- 14 Nov 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"ACORN BIOVENTURES, L.P. disclosed 7.6% ownership in Mural Oncology plc Common Stock, $0.01 par value per share (MURA) on 31 Dec 2024."
What Changed
- Previous schedule filing date: 14 Nov 2024.
- Current filing was accepted on 14 Feb 2025, 12:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 3.2% | 540,153 | 0 | 540,153 | Anders Hove | Manager | |
| ACORN BIOVENTURES 2, L.P. | 4.4% | 745,926 | 0 | 745,926 | Anders Hove | Manager | |
| ACORN CAPITAL ADVISORS GP, LLC | 3.2% | 540,153 | 0 | 540,153 | Anders Hove | Manager | |
| Acorn Capital Advisors GP 2, LLC | 4.4% | 745,926 | 0 | 745,926 | Anders Hove | Manager | |
| Anders Hove | 7.6% | 1,286,079 | 0 | 1,286,079 | Anders Hove | Manager |